1988
DOI: 10.1182/blood.v72.6.1891.1891
|View full text |Cite
|
Sign up to set email alerts
|

Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study

Abstract: The immunophenotypes of lymphoblasts from children with newly diagnosed T-cell acute lymphoid leukemia (T-ALL, n = 101) or T-cell non-Hodgkin lymphoma (T-NHL, n = 31) were analyzed to correlate stage of thymocyte differentiation with clinical features and outcome. The 67 boys and 34 girls with T-ALL were 1 month to 18 years old (median, 8 years) with leukocyte counts ranging from 2 to 810 x 10(9)/L (median, 55 x 10(9)/L). Eighteen of these patients were black, and 70 had a mediastinal mass. Twenty-six boys and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
32
0
2

Year Published

1994
1994
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 109 publications
(34 citation statements)
references
References 19 publications
0
32
0
2
Order By: Relevance
“…The immunophenotype of T-ALL and T-LBL corresponds with defined stages of intrathymic T-cell differentiation (Crist et al, 1988;Uckun et al, 1997). Precursor T-cells most commonly express CD7, CD5 and CD2, whereas CD3 is present in the cytoplasm (cyCD3) or on the surface (sCD3).…”
Section: Immunophenotypementioning
confidence: 99%
See 1 more Smart Citation
“…The immunophenotype of T-ALL and T-LBL corresponds with defined stages of intrathymic T-cell differentiation (Crist et al, 1988;Uckun et al, 1997). Precursor T-cells most commonly express CD7, CD5 and CD2, whereas CD3 is present in the cytoplasm (cyCD3) or on the surface (sCD3).…”
Section: Immunophenotypementioning
confidence: 99%
“…In general, T-ALL and T-LBL show overlapping immunophenotypic features, but some studies stated that T-LBL have antigen expression profiles consistent with more mature stages of intrathymic T-cell development than T-ALL (Bernard et al, 1981;Cossman et al, 1983;Weiss et al, 1986;Magrath, 1987;Sheibani et al, 1987;Crist et al, 1988;Freedman, 1996;Sandlund et al, 2003). However, attempts at separating T-LBL from T-ALL by immunophenotypic features have, on the whole, not met with success.…”
Section: Immunophenotypementioning
confidence: 99%
“…T-Precursor A.L.L. (23,81,102) is characteristically CD7(ϩ), CD5(ϩ) and CD2(ϩ), but CD3(Ϫ) or dim with cytoplasmic CD3 (cCD3)(ϩ) (46). CD4 and CD8 expression may be seen in all combinations, but are more often either both (Ϫ) or both (ϩ).…”
Section: Criteria For Diagnosing Particular Diseasesmentioning
confidence: 99%
“…[1][2][3][4] Historically, patients with T-ALL has had an inferior outcome compared with those with precursor-B ALL (B-ALL). [5][6][7] Patients with T-ALL tend to experience more induction failures and extramedullary (EM) relapses than their B-ALL counterparts. [8,9] They also frequently present with unfavorable clinical features, such as male gender, older age, high white blood cell (WBC) count, bulky EM disease, and central nervous system (CNS) involvement.…”
Section: Introductionmentioning
confidence: 99%